用户,您好,欢迎您进入NSTL重点领域信息门户! 登录 | 注册  帮助中心
重点领域信息门户
您当前的位置: 首页 > 重要报告详情

编译内容

编译服务: 结核病防治 编译者: 蒋君 编译时间: Dec 12, 2019 点击量: 5080

05 December 2019 I Geneva, Switzerland – The Stop TB Partnership’s Global Drug Facility (GDF) has expanded its Diagnostics Catalog by adding an IGRA (interferon-gamma release assay) test for latent TB infection. The products required to run the QuantiFERON-TB Gold Plus (QFT-Plus) IGRA are now available at a GDF-negotiated price of $15.90 per test by the manufacturer Qiagen (Hilden, Germany). This price is offered to any public sector or not-for-profit buyer in low- and middle-income countries when procuring through GDF. For the full listing of products, see the GDF Diagnostics Catalog.

 

提供服务
导出本资源